Professor of Business, Public Policy, and Medicine. Duke University. Interested in decision making.
Editor in Chief at Value in Health, Board chair at EuroQol Research Foundation, Rotterdam & Professor of Health Economics at University of Melbourne. Proud mum of three wonderful adults and grandma to two very energetic tiny humans.
Research Specialist @ PORTAL
Public health professional working on innovation and access to health products
Better health & economic development through better supply chains, globally. #globalhealth #supplychain #pharmaceuticals #vaccine #access
Access and Global Health Policy Lead, MSF UK. Personal account, views my own
Physician, Researcher, Advocate for the notion that an ounce of evidence is worth a pound of opinion. @brownpublichealth.bsky.social
My views are solely my own (who else would want them??)
law, technology, policy.
latest: https://academic.oup.com/jlb/article/12/1/lsaf012/8160132
health policy researcher, primary care physician, dad
The official BlueSky feed of the Brown University School of Public Health | Learn public health by doing public health. #BrownSPH
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18
All opinions are mine; I don’t speak for my employer in any way.
Stergachis Family Endowed Professor & Director, The CHOICE Institute (http://uwchoice.org), UW, Seattle, @amstatNews Fellow, @nberpubs RA. (he/him) 🐻 ⬇️
Welcome to the official Bluesky account for the New England Journal of Medicine. Follow for high-quality, peer-reviewed research and clinical content from the world’s leading medical journal, online at NEJM.org.
Follow @ai.nejm.org for medical AI content.
MPP aims to improve access to affordable #EssentialMedicines – including for treating #HIV #ViralHepatitis #TB #COVID-19 and #NCDs – in low- and middle-income countries through voluntary licensing and technology transfer.
medicinespatentpool.org
Interested in Shifting Powers towards Health Equity, Economic Justice, post-Finance Capitalism, Climate Justice, Equitable Access to Medicines and Vaccines, and a better future for all of us. Founding Director of æqua.
Health economics, health policy, and pools
https://vivo.brown.edu/display/cmwhaley
https://cahpr.sph.brown.edu/
Co-Director, Center for Global Health Policy & Politics, O'Neill Institute, Georgetown U
Access to medicines and diagnostics.
Law prof at Boston University. Health law, empirical methods, judgment and decision making.
Center for the Evaluation of Value and Risk in Health at Medical Center. Posts and reposts are not endorsements.
https://cevr.tuftsmedicalcenter.org/
Global health reporter, The New York Times. Former correspondent in South Asia, Africa, Latin America and the MidEast. Author, 28 Stories of AIDS in Africa; Promised the Moon. Baker. Canoe tripper. Disease nerd. Lover of a fat novel and Earl Grey tea.
Assistant Professor pharma & health law @uva-amsterdam.bsky.social - Co-Director, Law for Health & Life - NWO Veni laureate - research & teaching on global health & access to medicines via international & EU law - contributor Medicines Law & Policy
Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823.
🌐 thelancet.com
Affordability and Pricing Director at the GMCB. Former PDAB Executive Director. Arnold Ventures, Duke-Margolis, and NGA alum. Thoughts and musings are my own
The latest news & views about the pharmaceutical industry - and other stray thoughts - from Ed Silverman.. ex-WSJ .. statnews.com/pharmalot/
I have a newsletter. It's called Cost Curve. I write a lot about dull things like 340B reform and benefit design and the Value Flower.
You can probably Google it.
I write about medicine at STAT. This is biology's century. Every data point has a face.
Physician Scientist | Assistant Professor | Coined #Pharmacoequity |Alum HSPH MGH Medicine Einstein Med | Opinions mine
Primary care physician/health policy research @yaleschoolofmed.bsky.social; @ncspyale.bsky.social; healthy skeptic; @jama.com deputy editor; open science: YODAProject @yalecrrit.bsky.social @medrxivpreprint.bsky.social
Research Scientist at the Program on Regulation, Therapeutics, and Law @portalresearch.org and Lecturer, Harvard Medical School
Interests: prescription drugs, bioethics, health technology assessment, and justice
CEO @imakglobal.bsky.social. Renegade IP lawyer. Critically rethinking IP laws through (neo)colonial/neoliberal systems of power, and that empty word “innovation”.
PhDing on health care costs and access to medicines at University of Washington’s Institute for Health Metrics and Evaluation. Previous career at Swiss TPH and 🇸🇸🇸🇱🇲🇼. BA/MSPH from Johns Hopkins.
The BMJ is patient centred, evidence based, and independent. Help us improve the health of our world with the best science, journalism, education, and comment.
Economist, health policy researcher, occasional troublemaker. All postings my own.
The Leonard Davis Institute of Health Economics at the University of Pennsylvania (Penn LDI) is a national leader in advancing health policy through transformative research.
Explore our research and impact at ldi.upenn.edu.
Reporting from the frontiers of health & medicine.
Health economics, law, global health, and access to medicines.
https://melissajbarber.github.io. Views my own.
Prof of European Public Health LSHTM
Co-Director European Observatory on Health Systems & Policy
Member Independent SAGE
Past President BMA & EUPHA
Committed to 🇬🇧 rejoining 🇪🇺
https://www.lshtm.ac.uk/aboutus/people/mckee.martin
I work at https://keionline.org/jamie. Best known for work on intellectual property rights, and find most interesting ways to reform incentives and also build out global norms and mechanisms to increase the supply of public goods. Economics background.
Johns Hopkins Professor of Health Policy and Economics
RT not an endorsement. Opinions are mine.
JAMA is an international peer-reviewed general medical journal and a member of the JAMA Network family of journals.
🌐 JAMA.com
Associate professor of law at @nyulaw.bsky.social. Director of the Science, Health & Information Clinic (SHIC). He/him. https://chrismorten.com/
Vice President, Regulatory Policy & Intelligence at POLITICO's AgencyIQ. Writing about how the FDA regulates medical products for 15+ years. Author of the newsletter 'FDA Today'. Signal: AlecGaffney.01
Health economist & research fellow with the Program on Regulation, Therapeutics, & Law (PORTAL) at Harvard Medical School.
Interests: drug pricing/policy, health technology assessment, climate change.
Squamish, BC
www.linkedin.com/in/araymakers
I write about substance use and the drug overdose crisis for @statnews.com
https://www.statnews.com/staff/lev-facher/
Affordable, quality health care. For everyone.
About Us: https://buff.ly/3PTPkDt
Law professor. Researching and writing about innovation and access to new healthcare technologies, mostly in health law, FDA law, and patent law.
Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Our research helps improve quality, safety, & efficiency of medication use.
We are a team of lawyers, scientists, and health experts challenging systemic injustice and advocating for health equity in drug development and access.
Associate Professor of Health Policy and the History of Medicine, Yale School of Public Health. Vaccine policy, health policy-making, pharmaceuticals, FDA/CDC, etc. http://jschwartz.yale.edu
Senior editor, Endpoints News
Doctor @BrighamWomens | Associate Prof of Health Policy & Management @HarvardHPM @HarvardHSPH | @harvardmed | Faculty Director of BWH MLP Program
Johns Hopkins University and NBER. Current research focuses on the history and political economy of U.S. S&T policy, the economics of the NIH, and pharmaceutical patent policy. Website: bhavensampat.github.io
Lung & ICU doctor | Faculty @harvardmed & @PORTAL_Research | Ethics Co-Chair @BrighamWomens
Working towards global ecological balance with bacteria. Married to Marya 38 years and counting. Professor at Boston University. All skeets my own.
I research insurance design, pharmacy closures, and high-cost prescription drugs. Faculty at the Harvard/Brigham & Women’s PORTAL group. Alum of Hopkins Health Policy and Management and UVA Batten.
Posting on public health topics … some interesting photos if I manage to take them … & occasionally the Baltimore Orioles.
haematology registrar PMCC & RMH | research affiliate, PORTAL, BWH/HMS | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer
Medical oncologist and health services researcher. Focusing on health care costs, physician-industry COI, and oncology reimbursement reform. Opinions mine.
Assistant Professor of Population Medicine
Harvard Pilgrim Health Care Institute and Harvard Medical School
Faculty Director, JD/MPH Program
Harvard T.H. Chan School of Public Health
Academic lawyer/bioethicist studying pharmaceutical policy, access to investigational medicines, IRB quality (www.aereo.org), and clinical research ethics and regulation, with a splash of psychedelics.
Research Director at Public Citizen's Access to Medicines program.
Former journalist covering intersection of pharma, health policy & politics.
On Signal at SarahKarlinSmith.34
Views are mine.
MD JD MPH FCLM FAMWA • Associate Prof @SLUHealthLaw.bsky.social @SLULAW.bsky.social • Former #NUSLHealth @PORTALResearch.org #HarvardMIT_CRS #HeForShe • 🇮🇸 🇮🇳 🇺🇸
Primary care physician and health services researcher. General medicine fellow at Harvard/BIDMC. Studying how to improve quality of care for older adults. https://linktr.ee/audreydzhang
Penn professor, bioethicist, oncologist, and New York Times bestselling author of "Eat Your Ice Cream: Six Simple Rules for a Long and Healthy Life."
Assistant Professor, primary care physician, and health services researcher at Yale School of Medicine, Co-Director of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT); *views expressed here are my own*
Clin epi / health economics, focus on the evidence and science, fan of sanity
Primary care doc, health policy researcher @portalresearch.org. Trying to make prescription drugs more affordable. 💊🩺📊
Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
Professor of Medicine, Brigham and Women's Hospital/Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL)
Academic research center at Brigham and Women's Hospital & Harvard Medical School studying the clinical, economic, and legal aspects of medication use.
RETHINKING MEDICATIONS by Jerry Avorn - Out Now! https://rethinkmeds.info/
